Shalini Shenoy
Pediatric Hematology-Oncology · Saint Louis, MONPI 1538185756
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $18,980 of the $24,531 with a category attached, or 77.4%. 14 manufacturers reported payments, led by Genetix Biotherapeutics Inc at 38.4% of the total. Among pediatric hematology-oncology clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 20 payments — averaging $1226.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genetix Biotherapeutics Inc$9K
- Mesoblast, Inc.$3K
- Takeda Pharmaceuticals U.S.A., Inc.$3K
- Biolinerx USA, Inc.$3K
- E.r. Squibb & Sons, L.L.C.$2K
- Medexus Pharma, Inc.$2K
- plus $2K from 8 others
Across 96 payments — averaging $2601.21 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$77K
- Pharmacyclics LLC, An Abbvie Company$71K
- National Marrow Donor Program$39K
- Jazz Pharmaceuticals Inc.$30K
- Mallinckrodt Hospital Products Inc.$25K
- Adaptive Biotechnologies Corporation$8K
What the payments were for
- Consulting fees$18,98077%
- Speaking & faculty fees$4,33818%
- Food & beverage$1,0294%
- Education$1841%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genetix Biotherapeutics Inc | 3 | $9,412 |
| Mesoblast, Inc. | 2 | $3,262 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $3,038 |
| Biolinerx USA, Inc. | 1 | $2,625 |
| E.r. Squibb & Sons, L.L.C. | 1 | $2,100 |
| Medexus Pharma, Inc. | 1 | $2,040 |
| Janssen Scientific Affairs, LLC | 1 | $1,010 |
| Novartis | 2 | $243 |
| National Marrow Donor Program | 1 | $215 |
| Amgen | 2 | $184 |
| Syndax Pharmaceuticals, Inc. | 1 | $135 |
| Adaptive Biotechnologies Corporation | 1 | $114 |
| Jazz Pharmaceuticals Inc. | 1 | $100 |
| Ipsen Biopharmaceuticals, Inc | 2 | $54 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$24,531 in reported general payments places this provider in the 90th percentile of 78 pediatric hematology-oncology providers in Missouri.
See all pediatric hematology-oncology providers in Missouri →
Other pediatric hematology-oncology in Saint Louis
- Mohamed AbdelbakiSaint Louis$50K
- Amy ArmstrongSaint Louis$42K
- Melanie FieldsSaint Louis$29K
- Jeffrey BednarskiSaint Louis$11K
- Nicole BrossierSaint Louis$11K
- Jorge DipaolaSaint Louis$6K
- Bryan SiskSaint Louis$6K
- Michael Angelo HuangSaint Louis$4K
- William FergusonSaint Louis$4K
- Jeffrey MageeSaint Louis$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.